Objective  To investigate the latest developments and research trends in the research field of Corona Virus Disease 2019 (COVID-19). 

Methods  The COVID-19-related literatures were retrieved from the Web of Science database since December 1, 2019 to November 15, 2020 and CiteSpace software was used to visualize the data. 

Results  As of November 15, 2020, more than 58,000 COVID-19 related articles have been retrieved. The Lancet is the magazine that publishes the most COVID-19 articles; the United States is the country that publishes the most COVID-19 articles, followed by China. As far as the author is concerned, Zhang WEI is the author who has published the most COVID-19 articles, with 45 articles published so far, and the author with the highest citation rate is Huang CL. A total of 15 clusters were formed by co-citation analysis of documents. Cluster #0 Hydroxychloroquine is the largest cluster. 

Conclusion  The United States and China are the main research contributors in the field of COVID-19. The clinical manifestations, infection mechanism and clinical diagnosis of COVID-19 are the main research areas, while the patient prognosis are research trends. 

1. World Health Organization. Novel coronavirus - China. (2020-1-12)[Access on 2020-11-25]. http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en.

2. 国家卫健康生委员会.新型冠状病毒传播途径与预防指南[EB/OL]. (2020-01-27)[Access on 2020-11-25]. http://www.nhc.gov.cn/jkj/s3578/202001/9e73060017d744aeafff8834fc0389f4.shtml. 

3. 国家卫生健康委员会办公厅.截至11月15日24时新型冠状病毒肺炎疫情最新情况[EB/OL]. (2020-11-15)[Access on 2020-11-25].http://www.nhc.gov.cn/yjb/s7860/202011/ad806976acce438ab5c48e187e907fc1.shtml.

4. 张旭, 董亚琼. 新冠肺炎(COVID-19)的致死率分析与治疗对策[J]. 基因组学与应用生物学, 2020, 39(9): 4405-4408. DOI: 10.13417/j.gab.039.004405. [Zhang X, Dong YQ. Fatality rate analysis and treatment strategies of COVID-19[J]. Genomics and Applied Biology, 2020, 39(9): 4405-4408.]

5. 陈悦, 陈超美,刘则渊,等. CiteSpace知识图谱的方法论功能[J].科学学研究, 2015, 33(2): 242-253. DOI: 10.16192/j.cnki.1003-2053.2015.02.009. [Chen Y, Chen CM, Liu ZY, et al. The methodology function of CiteSpace mapping knowledge domains[J]. Studies in Science of Science, 2015, 33(2): 242-253]

6. Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping[J]. Scientometrics, 2010, 84(2): 523-538. DOI: 10.1007/s11 192-009-0146-3.

7. 张君国, 杨波, 高天敏. 新型冠状病毒肺炎的治疗进展[J]. 病毒学报, 2021, 37(1): 201-210. DOI: 10.13242/j.cnki.bingduxuebao.003828. [Zhang JG, Yang B, Gao TM. Progress in the treatment of new coronavirus pneumonia[J]. Chinese Journal of Virology, 2021, 37(1): 201-210.]

8. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J]. Cell Res, 2020, 30(3): 269-271. DOI: 10.1038/s41422-020-0282-0.

9. Cavalcanti AB, Zampieri FG, Rosa RG, et al.  Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19[J]. N Engl J Med, 2020, 383(21): 2041-2052. DOI: 10.1056/NEJMOA2019014.

10.  新冠肺炎诊疗方案治疗药物信息汇编（第二版）[J/OL].中南药学: 1-31. [Access on 2021-01-28]. http://kns.cnki.net/kcms/detail/43.1408.R.20200423.0902.002.html.

11.  史河水, 韩小雨, 樊艳青, 等. 新型冠状病毒（2019-nCoV）感染的肺炎临床特征及影像学表现[J]. 临床放射学杂志, 2020, 39(1): 8-11. DOI: 10.13437/j.cnki.jcr.20200206.002. [Shi HS, Han XY, Fan YQ, et al. Radiologic features of patients with 2019-nCoV infection[J]. Journal of clinical radiology, 2020, 39(1): 8-11.]

12.  Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention[J]. JAMA, 2020, 323(13): 1239-1242. DOI: 10. 1001/jama.2020.2648.

13.  Guan WJ, Zhong NS. Clinical characteristics of COVID-19 in China[J]. N Engl J Med, 2020, 382(19): 1861-1862. DOI: 10.1056/NEJMc2005203.

14.  Sun L, Shen L, Fan J, et al. Clinical features of patients with coronavirus disease 2019 from a designated hospital in Beijing, China[J]. Med Virol, 2020, 92(10): 2055-2066. DOI: 10.1002/jmv.25966.

15.  Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA, 2020, 323(11): 1061-1069. DOI: 10.1001/JAMA.2020.1585.

16.  Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506. DOI: 10.1016-S0 140-6736(20)30183-5.

17.  Kang Y, Chen T, Mui D, et al. Cardiovascular manifestations and treatment considerations in COVID-19[J]. Heart, 2020, 106(15): 1132-1141. DOI: 10.1136/heartjnl-2020-317056.

18.  Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China[J]. JAMA Neurol, 2020, 77(6): 683-690. DOI: 10.1001/jamaneurol.2020.1127.

19.  Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses[J]. Brain Behav Immun, 2020, 87: 18-22. DOI: 10.1016/j.bbi.2020.03.031.

20.  吕飞, 丁祥武, 骆忠华, 等. 新型冠状病毒肺炎患者消化系统表现的回顾性研究[J]. 世界华人消化杂志, 2020, 28(14): 628-636. DOI: 10.11569/wcjd.v28.i14.62. [Lv F, Ding XW, Luo ZH, et al. Retrospective analysis of digestive system manifestations in patients with coronavirus disease 2019[J]. World Journal of Chinese Digestion, 2020, 28(14): 628-636.] 

21.  祝敏, 王婉婷, 曹钰, 等. 新型冠状病毒肺炎并发肾损伤的发病机制及诊治进展[J/OL].华西医学, 2020, 11: 1294-1298. DOI: 10.7507/1002-0179.202003186. [Zhu M, Wang WT, Cao Y, et al. The pathogenesis, diagnosis and treatment progress of coronavirus disease 2019 complicated by renal injury[J/OL]. West China Medical Journal, 2020, 11: 1294-1298]

22.  Li MY, Li L, Zhang Y, et al. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues[J]. Infect Dis Poverty, 2020, 9(1): 45. DOI: 10.1186/S40249-020-00662-X. 

23.  Hui DS, Azhar EI, Kim YJ, et al. Middle east respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission[J]. Lancet Infect Dis, 2018,18(8): e217-e227. DOI: 10.1016/S1473-3099(18)30127-0.

24.  Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome[J]. Nat Med, 2004, 10: S88-S97. DOI: 10.1038/nm1143.

25.  Lukassen S, Chua RL, Trefzer T, et al. SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells[J]. EMBO J, 2020, 39(10): e105114. DOI: 10.15252/EMBJ.20105114.

26.  Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor[J]. Cell, 2020, 181(2): 271-280.e8. DOI: 10.1016/j.cell. 2020.02.052.

27.  Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation[J].bioRxiv[Preprint], 2020, 2020.02.11.944462. DOI: 10.11 01/2020.02.11.944462. 

28.  Aghemo A, Piovani D, Parigi TL, et al. COVID-19 digestive system involvement and clinical outcomes in a large academic hospital in Milan, Italy[J]. Clin Gastroenterol Hepatol, 2020, 18(10): 2366-2368. DOI: 10.1016/J.CGH.2020.05.011.

29.  Hasan A, Paray BA, Hussain A,et al. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin[J]. J Biomol Struct Dyn, 2020: 1-9, DOI: 10.1080/07391102.2020.1754293.